AAAAAA
Results: 1-25/49
Authors:
Xuan, DW
Turley, C
Nightingale, CH
Nicolau, DP
Citation: Dw. Xuan et al., Determination of BMS-284756, a new quinolone, in mouse serum by high-performance liquid chromatography with fluorescence detection, J CHROMAT B, 765(1), 2001, pp. 37-43
Authors:
McNabb, J
Ross, JW
Abriola, K
Turley, C
Nightingale, CH
Nicolau, DP
Citation: J. Mcnabb et al., Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic, CLIN INF D, 33(5), 2001, pp. 700-705
Authors:
Owens, RC
Tessier, P
Nightingale, CH
Ambrose, PG
Quintiliani, R
Nicolau, DP
Citation: Rc. Owens et al., Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens, INT J ANT A, 17(6), 2001, pp. 483-489
Authors:
Nicolau, DP
McNabb, J
Lacy, MK
Quintiliani, R
Nightingale, CH
Citation: Dp. Nicolau et al., Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia, INT J ANT A, 17(6), 2001, pp. 497-504
Authors:
Kim, MK
Xuan, DW
Quintiliani, R
Nightingale, CH
Nicolau, DP
Citation: Mk. Kim et al., Pharmacokinetic and pharmacodynamic profile of high dose extended intervalpiperacillin-tazobactam, J ANTIMICRO, 48(2), 2001, pp. 259-267
Authors:
McNabb, JCJ
Nightingale, CH
Quintiliani, R
Nicolau, DP
Citation: Jcj. Mcnabb et al., Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia, PHARMACOTHE, 21(5), 2001, pp. 549-555
Authors:
Nicolau, DP
Onyeji, CO
Banevicius, MA
Li, J
Nightingale, CH
Citation: Dp. Nicolau et al., Effects of adjunctive treatment with combined cytokines in a neutropenic mouse model of multidrug-resistant Enterococcus faecalis septicemia, PHARMACOTHE, 21(3), 2001, pp. 275-280
Authors:
Mattoes, HM
Banevicius, M
Li, DD
Turley, C
Xuan, DW
Nightingale, CH
Nicolau, DP
Citation: Hm. Mattoes et al., Pharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae, ANTIM AG CH, 45(7), 2001, pp. 2092-2097
Authors:
Xuan, DW
Zhong, MK
Mattoes, H
Bui, KQ
McNabb, J
Nicolau, DP
Quintiliani, R
Nightingale, CH
Citation: Dw. Xuan et al., Streptococcus pneumoniae response to repeated moxifloxacin or levofloxacinexposure in a rabbit tissue cage model, ANTIM AG CH, 45(3), 2001, pp. 794-799
Authors:
Bui, KQ
Ambrose, PG
Nicolau, DP
Lapin, CD
Nightingale, CH
Quintiliani, R
Citation: Kq. Bui et al., Pharmacokinetics of high-dose meropenem in adult cystic fibrosis patients, CHEMOTHERA, 47(3), 2001, pp. 153-156
Authors:
Xuan, DW
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Dw. Xuan et al., Circulating tumor necrosis factor-alpha production during the progression of rat endotoxic sepsis, CHEMOTHERA, 47(3), 2001, pp. 194-202
Authors:
Nightingale, CH
Citation: Ch. Nightingale, A survey of the quality of generic clarithromycin products from 13 countries, CLIN DRUG I, 19(4), 2000, pp. 293-305
Authors:
Grant, EM
Zhong, MK
Ambrose, PG
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Em. Grant et al., Stability of meropenem in a portable infusion device in a cold pouch, AM J HEAL S, 57(10), 2000, pp. 992-995
Authors:
McNabb, J
Lacy, MK
Ross, JW
Rousseau, M
Nightingale, CH
Nicolau, DP
Citation: J. Mcnabb et al., Randomized, crossover adherence trial of azithromycin and clarithromycin for Mycobacterium avium complex prophylaxis in AIDS patients, INF DIS C P, 9(1), 2000, pp. 27-32
Authors:
McNabb, J
Owens, RC
Xuan, DW
Quintiliani, R
Nightingale, CH
Nicolau, DP
Citation: J. Mcnabb et al., Comparison of azithromycin leukocyte disposition in healthy volunteers andvolunteers with AIDS, INT J ANT A, 16(1), 2000, pp. 37-43
Authors:
Xuan, DW
Lu, JF
Nicolau, DP
Nightingale, CH
Citation: Dw. Xuan et al., Population pharmacokinetics of tobramycin in hospitalized patients receiving once-daily dosing regimen, INT J ANT A, 15(3), 2000, pp. 185-191
Authors:
Lacy, MK
Tessier, PR
Nicolau, DP
Nightingale, CH
Quintiliani, R
Citation: Mk. Lacy et al., Comparison of vancomycin pharmacodynamics (1 g every 12 or 24 h) against methicillin-resistant staphylococci, INT J ANT A, 15(1), 2000, pp. 25-30
Authors:
Nightingale, CH
Citation: Ch. Nightingale, A survey of the quality of generic clarithromycin products manufactured inSlovenia and Israel, ADV THER, 17(3), 2000, pp. 167-178
Authors:
Tessier, PR
Nightingale, CH
Nicolau, DP
Citation: Pr. Tessier et al., Postantibiotic effect of trovafloxacin against Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis in cerebrospinal fluid and broth culture media, DIAG MICR I, 36(4), 2000, pp. 241-247
Authors:
Lu, JF
Nightingale, CH
Citation: Jf. Lu et Ch. Nightingale, Magnesium sulfate in eclampsia and pre-eclampsia pharmacokinetic principles, CLIN PHARMA, 38(4), 2000, pp. 305-314
Authors:
Onyeji, CO
Nicolau, DP
Nightingale, CH
Bow, L
Citation: Co. Onyeji et al., Modulation of efficacies and pharmacokinetics of antibiotics by granulocyte colony-stimulating factor in neutropenic mice with multidrug-resistant Enterococcus faecalis infection, J ANTIMICRO, 46(3), 2000, pp. 429-436
Authors:
Bui, KQ
Banevicius, MA
Nightingale, CH
Quintiliani, R
Nicolau, DP
Citation: Kq. Bui et al., In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa, J ANTIMICRO, 45(1), 2000, pp. 57-62
Authors:
Ernst, EJ
Klepser, ME
Klepser, TB
Nightingale, CH
Hunsicker, LG
Citation: Ej. Ernst et al., Comparison of the serum and intracellular pharmacokinetics of azithromycinin healthy and diabetic volunteers, PHARMACOTHE, 20(6), 2000, pp. 657-661
Authors:
Nightingale, CH
Citation: Ch. Nightingale, Moxifloxacin, a new antibiotic designed to treat community-acquired respiratory tract infections: A review of microbiologic and pharmacokinetic pharmacodynamic characteristics, PHARMACOTHE, 20(3), 2000, pp. 245-256
Authors:
McNabb, J
Quintiliani, R
Nicolau, DP
Grant, E
Nightingale, CH
Citation: J. Mcnabb et al., Cost-effectiveness in the use of antibiotics, CURR CLIN I, 20, 2000, pp. 24-42